Skip to main content
. 2023 Oct 18;32(170):230084. doi: 10.1183/16000617.0084-2023

TABLE 3.

Studies investigating the effects of inhaled corticosteroids (ICS) on microbiome changes

First author, year [ref.] Type of study Sample Bacterial detection method COPD patients
ICS/no ICS
Key findings
Bacterial load Species change Diversity
Garcha, 2012 [ 132 ] Cohort Sputum qPCR 47/5 = X
Wang, 2019 [ 124 ] Cohort Sputum 16S rRNA+qPCR 25/7 = H. influenzae
M. catarrhalis
Ramsheh, 2021 [ 126 ] Cohort Bronchial brush 16S rRNA 192/147 = =
Beech, 2020 [ 125 ] Cohort Sputum qPCR 199/37 = = X
Beech, 2021 [ 46 ] Cohort Sputum qPCR 43/17 = = X
Singanayagam, 2019 [ 134 ] Cohort Sputum 16S rRNA 10/13 S. pneumoniae X
Contoli, 2017 [ 98 ] RCT Sputum qPCR 30/30 H. influenzae#
S. pneumoniae#
Leitao Filho, 2021 [ 135 ] RCT Bronchial brush 16S rRNA 18 FP/20 = Haemophilus
↑ Firmicutes
18 BD/20 = = =

=: no change; ↑: increase; ↓: decrease; X: not measured. qPCR: quantitative PCR; 16S rRNA: 16S ribosomal RNA gene sequencing; H. influenzae: Haemophilus influenzae; M. catarrhalis: Moraxella catarrhalis; S. pneumoniae: Streptococcus pneumoniae; RCT: randomised controlled trial; FP: fluticasone propionate; BD: budesonide. #: in eosinophil-low patients.